Arthrosurface Gains FDA Clearance for BOSS Toe Fixation

Arthrosurface received FDA 510(k) clearance to market the BOS's Toe Fixation system for patients who want to avoid joint fusion and return to an active lifestyle.

BOSS is intended to improve stabilization in a first metatarsal that presents with a distal bone void, and provides patients with a motion-preserving alternative to fusion.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us